Literature DB >> 11844284

New era for digital ECG: FDA requires digital ECG submission for tested drugs.

Wojciech Zareba.   

Abstract

Mesh：

Year:  2002        PMID： 11844284      PMCID： PMC7027728          DOI： 10.1111/j.1542-474x.2001.tb00131.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN： 1082-720X            Impact factor:   1.468


× No keyword cloud information.
  5 in total

1.  The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology.

Authors:  W Haverkamp; G Breithardt; A J Camm; M J Janse; M R Rosen; C Antzelevitch; D Escande; M Franz; M Malik; A Moss; R Shah
Journal:  Cardiovasc Res       Date:  2000-08       Impact factor: 10.787

2.  ISHNE guidelines for electrocardiographic evaluation of drug-related QT prolongation and other alterations in ventricular repolarization: task force summary. A report of the Task Force of the International Society for Holter and Noninvasive Electrocardiology (ISHNE), Committee on Ventricular Repolarization.

Authors:  A J Moss; W Zareba; J Benhorin; J P Couderc; H Kennedy; E Locati-Heilbron; P Maison-Blanche
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-10       Impact factor: 1.468

3.  Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.

Authors:  I Splawski; J Shen; K W Timothy; M H Lehmann; S Priori; J L Robinson; A J Moss; P J Schwartz; J A Towbin; G M Vincent; M T Keating
Journal:  Circulation       Date:  2000-09-05       Impact factor: 29.690

4.  The long QT syndrome. Prospective longitudinal study of 328 families.

Authors:  A J Moss; P J Schwartz; R S Crampton; D Tzivoni; E H Locati; J MacCluer; W J Hall; L Weitkamp; G M Vincent; A Garson
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

5.  Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group.

Authors:  W Zareba; A J Moss; P J Schwartz; G M Vincent; J L Robinson; S G Priori; J Benhorin; E H Locati; J A Towbin; M T Keating; M H Lehmann; W J Hall
Journal:  N Engl J Med       Date:  1998-10-01       Impact factor: 91.245
  5 in total
  2 in total

Review 1.  Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development.

Authors:  Vaibhav Salvi; Dilip R Karnad; Gopi Krishna Panicker; Snehal Kothari
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

2.  ElVisML: an open data format for the exchange and storage of electrophysiological data in ophthalmology.

Authors:  Torsten Strasser; Tobias Peters; Herbert Jägle; Eberhart Zrenner
Journal:  Doc Ophthalmol       Date:  2017-11-11       Impact factor: 2.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.